Skip to main content
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd — Investor Relations & Filings

Ticker · CLGN ISIN · IL0004960188 US Manufacturing
Open in API
Filings indexed 306 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country US United States of America
Listing US CLGN

About CollPlant Biotechnologies Ltd

https://www.collplant.com

CollPlant Biotechnologies is a regenerative and aesthetic medicine company developing technologies and products for tissue regeneration and organ manufacturing. The company's core technology is a proprietary, plant-derived recombinant human collagen (rhCollagen) that is used in its 3D bioprinting platform. This platform enables the production of bio-inks for printing tissues and scaffolds. Key areas of development include medical aesthetics, such as next-generation regenerative breast implants, and the 3D bioprinting of tissues and organs for various medical applications.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 75% confidence The document is a Form 6-K “Report of Foreign Private Issuer” filed with the U.S. SEC, incorporating by reference a press release on Q1 2026 financial results (Exhibit 99.1). It is a regulatory SEC filing of a foreign private issuer furnishing information, not the full annual or interim report itself. Under our taxonomy this falls under Regulatory Filings (RNS).
2026-05-29 English
424B3 - CollPlant Biotechnologies Ltd (0001631487) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a prospectus related to the resale of ordinary shares by selling shareholders, including details about the number of shares, warrants, use of proceeds, plan of distribution, risk factors, and recent developments. It is a registration statement filed with the SEC, specifically a Form 424B3, which is a prospectus supplement used in securities offerings. This type of document is related to capital raising and financing activities, describing the terms and conditions of the share resale offering. It is not an annual report, earnings release, or management discussion, nor is it a proxy statement or voting results announcement. The document fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes through the resale of shares by selling shareholders.
2026-04-21 English
6-K - CollPlant Biotechnologies Ltd (0001631487) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a notification about the termination of a development agreement and a press release attached as an exhibit. The document is relatively short (2626 characters) and primarily serves as an announcement of events and filings rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2026-04-13 English
6-K - CollPlant Biotechnologies Ltd (0001631487) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a press release dated March 26, 2026, titled 'CollPlant Biotechnologies Reports 2025 Financial Results and Provides Corporate Update,' which is attached as Exhibit 99.1. The document itself is short (1788 characters) and primarily serves to announce the press release and provide the signature of the authorized officer. There is no substantive financial data or detailed report content within this document. According to the 'Menu vs Meal' rule, this is an announcement of a report (the press release) rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such filings that do not fit other specific categories.
2026-03-26 English
20-F - CollPlant Biotechnologies Ltd (0001631487) (Filer)
Annual Report FY 2025
2026-03-26 English
3 - CollPlant Biotechnologies Ltd (0001631487) (Issuer)
Director's Dealing
2026-03-18 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.